As the UK medical cannabis sector continues to evolve, there is increasing demand for compliant packaging services supporting the supply of unlicensed medicinal cannabis products.
RX Extraction is currently progressing regulatory licensing with the Medicines and Healthcare products Regulatory Agency (MHRA) to enable Specials manufacturing and packing activities.
Subject to regulatory approval, this capability will allow the company to support the compliant packaging of unlicensed medicinal products in accordance with applicable UK pharmaceutical regulations.
This planned service is intended to support healthcare providers, pharmacies, and supply partners operating within the UK Specials framework.
Further details regarding scope, service availability, and operational timelines will be confirmed following completion of the relevant licensing process.
